Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study.
Journal: Current rheumatology reports
Published: April 16, 2026
Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversion.
Journal: medRxiv : the preprint server for health sciences
Published: February 27, 2026
Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapy.
Journal: Rheumatology (Oxford, England)
Published: September 04, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 05, 2025
A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 05, 2025
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial.
Journal: Seminars in arthritis and rheumatism
Published: May 05, 2025
Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial.
Journal: Arthritis care & research
Published: February 06, 2025
Long-Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration.
Journal: Arthritis care & research
Published: January 04, 2025
Gout Flares After Stopping Anti-Inflammatory Prophylaxis: A Rapid Literature Review and Meta-Analysis.
Journal: Arthritis care & research
Published: August 15, 2024
TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapy.
Journal: Cellular & molecular immunology
Published: July 10, 2024
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement activation and inflammation modulators.
Journal: Research square
Published: May 20, 2024
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators.
Journal: Scientific reports
Published: April 17, 2024
Last Updated: 09/26/2026